Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 1c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.46), $0.01 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $2.69 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
• Snowflake soars 20% on earnings beat and raised guidance